RICHARDSON LINDA M (EVP & Chief Commercial Officer) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/16/2023ACC: 0001104659-23-022788
Officer· EVP & Chief Commercial Officer
Since Feb 2021
-386.00
Net shares
Net seller
$8.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
386.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−386.00
Price / share
$21.21
Trade value
$8.19K
% of position
0.9%
2/14/2023
43.68K→43.29K
Total
Net shares
−386.00
Net value
-$8.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2023 | F · Tax Withholding | −386.00 | $21.21 | $8.19K | 0.9% | 43.68K | 43.29K |
| Total | −386.00 | -$8.19K | ||||||
Derivative Transactions0
No derivative transactions reported